Baxter and Coherus Biosciences have entered into an exclusive collaboration to develop and commercialize a biosimilar of Amgen's rheumatoid arthritis drug, etanercept, for Europe, Canada ...

"This action reflects our strategic priority to optimize the portfolio and enhance focus in specific disease areas as Baxter's BioScience organisation prepares to become a separate, independent ...